PT Kalbe Farma Tbk

Research PT Kalbe Farma Tbk (LCLA) on Bullrun: market cap EUR 2.13B, dividend yield 2.9%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerLCLA
• ExchangeF
• CountryIndonesia
• SectorHealthcare
• IndustryDrug Manufacturers - General
• CurrencyEUR
• Market capEUR 2.13B
• Dividend yield2.9%
• Financial periodQ4 2025
• RevenueEUR 9.34T
• Net incomeEUR 1.03T
• Free cash flowEUR 836.45B
• Gross margin37.5%

Valuation Snapshot

latest market cap is EUR 2.13B; dividend yield is 2.9%.

About PT Kalbe Farma Tbk

PT Kalbe Farma Tbk., together with its subsidiaries, engages in the development, manufacture, and trading of pharmaceutical products in Indonesia. It operates through Prescription Pharmaceuticals; Consumer Health; Nutritionals; and Distribution and Logistic segments. The company provides prescription/ethical; consumer health; nutritionals; distribution and logistics; health services; medical devices; biopharma; animal health; international business, and E-health products.

Frequently asked questions

What is PT Kalbe Farma Tbk's market cap?

PT Kalbe Farma Tbk's market capitalization is EUR 2.13B.

Does PT Kalbe Farma Tbk pay a dividend?

PT Kalbe Farma Tbk has a dividend yield of 2.9%.

What does PT Kalbe Farma Tbk do?

PT Kalbe Farma Tbk., together with its subsidiaries, engages in the development, manufacture, and trading of pharmaceutical products in Indonesia. It operates through Prescription Pharmaceuticals; Consumer Health; Nutritionals; and Distribution and Logistic segments.